DOI:
10.1055/s-00000085
The Thoracic and Cardiovascular Surgeon
LinksClose Window
References
Engstrøm T, Kelbæk H, Helqvist S. et al; DANAMI-3—PRIMULTI Investigators.
Complete revascularisation versus treatment of the culprit lesion only in patients with ST-segment elevation myocardial infarction and multivessel disease (DANAMI-3—PRIMULTI): an open-label, randomised controlled trial.
Lancet 2015;
386 (9994): 665-671
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.